Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)-Reference-Cited by-同舟云学术

Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)

Published:2005 Issue:7 Volume:52 Page:2168-2178
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Seo Philip,Min Yuan-I.,Holbrook Janet T.,Hoffman Gary S.,Merkel Peter A.,Spiera Robert,Davis John C.,Ytterberg Steven R.,St. Clair E. William,McCune W. Joseph,Specks Ulrich,Allen Nancy B.,Luqmani Raashid A.,Stone John H.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference22 articles.

1. Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis)

2. The Use of Alkylating Agents in the Treatment of Wegener's Granulomatosis

3. Wegener Granulomatosis: An Analysis of 158 Patients

4. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients

5. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasculitides and Other Causes of Pulmonary Hemorrhage;Pulmonary Pathology;2025

2. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Pediatric Patient Presenting With Hemoptysis;Cureus;2024-09-04

3. Distinct pulmonary patterns in ANCA-associated vasculitides: insights from a retrospective single center cohort study;Rheumatology International;2024-08-13

4. Treatment goals in ANCA-associated vasculitis: defining success in a new era;Frontiers in Immunology;2024-06-13

5. Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use;BMC Rheumatology;2024-04-28